Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss

Bisphosphonate is widely used to treat patients with primary and secondary osteoporosis. The chronic administration of furosemide is considered a risk factor for osteoporosis mainly due to the increased urinary excretion of calcium, leading to a long-term negative balance of calcium. We describe two...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kubota, Takuo, Namba, Noriyuki, Kurotobi, Shunji, Kogaki, Shigetoyo, Hirai, Haruhiko, Kitaoka, Taichi, Nakajima, Shigeo, Ozono, Keiichi
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society for Pediatric Endocrinology 2006
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004841/
https://ncbi.nlm.nih.gov/pubmed/24790329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.15.101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados